Samsung Biologics ranked among the top searched stocks for 14 days in the past month.

As of 12:33 PM on the 19th, Samsung Biologics is trading at 795,000 KRW, down 1.85% from the previous day. This represents a 30.11% increase compared to May 28. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners have sold a net 3,593 shares of Samsung Biologics, while institutions have bought a net 4,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 55,035 shares, while foreigners and institutions have sold a net 35,959 shares and 22,068 shares, respectively.

On June 15, Samsung Biologics was a market topic with the headline "Record High... Five Consecutive Days of Gains."



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing